Seres Therapeutics Stock Price History
MCRB Stock | USD 0.76 0.02 2.32% |
Below is the normalized historical share price chart for Seres Therapeutics extending back to June 26, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Seres Therapeutics stands at 0.76, as last reported on the 26th of February, with the highest price reaching 0.76 and the lowest price hitting 0.76 during the day.
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0594, which indicates the firm had a -0.0594 % return per unit of risk over the last 3 months. Seres Therapeutics exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Seres Therapeutics' Risk Adjusted Performance of 0.0837, coefficient of variation of 981.1, and Semi Deviation of 3.36 to confirm the risk estimate we provide.
At present, Seres Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 163 K, whereas Total Stockholder Equity is projected to grow to (38.4 M). . As of February 26, 2025, Price To Sales Ratio is expected to decline to 1.21. In addition to that, Price Earnings Ratio is expected to decline to -1.49. Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2015 | 200 Day MA 0.8913 | 50 Day MA 0.8456 | Beta 2.098 |
Seres |
Sharpe Ratio = -0.0594
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MCRB |
Estimated Market Risk
4.82 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Seres Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding Seres Therapeutics to a well-diversified portfolio.
Price Book 5.6384 | Enterprise Value Ebitda (2.07) | Price Sales 1.0671 | Shares Float 124.8 M | Wall Street Target Price 3.874 |
Seres Therapeutics Stock Price History Chart
There are several ways to analyze Seres Stock price data. The simplest method is using a basic Seres candlestick price chart, which shows Seres Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 29, 2024 | 0.98 |
Lowest Price | January 21, 2025 | 0.73 |
Seres Therapeutics February 26, 2025 Stock Price Synopsis
Various analyses of Seres Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Seres Stock. It can be used to describe the percentage change in the price of Seres Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Seres Stock.Seres Therapeutics Price Action Indicator | (0.01) | |
Seres Therapeutics Price Rate Of Daily Change | 0.98 |
Seres Therapeutics February 26, 2025 Stock Price Analysis
Seres Stock Price History Data
The price series of Seres Therapeutics for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 0.4 with a coefficient of variation of 8.13. The daily prices for the period are spread out with arithmetic mean of 0.84. The median price for the last 90 days is 0.84.Open | High | Low | Close | Volume | ||
02/26/2025 | 0.78 | 0.76 | 0.76 | 0.76 | ||
02/25/2025 | 0.79 | 0.80 | 0.76 | 0.78 | 698,503 | |
02/24/2025 | 0.81 | 0.82 | 0.77 | 0.79 | 375,550 | |
02/21/2025 | 0.81 | 0.83 | 0.80 | 0.80 | 907,838 | |
02/20/2025 | 0.82 | 0.85 | 0.80 | 0.81 | 652,953 | |
02/19/2025 | 0.82 | 0.85 | 0.82 | 0.83 | 292,418 | |
02/18/2025 | 0.83 | 0.86 | 0.81 | 0.83 | 1,230,331 | |
02/14/2025 | 0.84 | 0.86 | 0.83 | 0.83 | 491,114 | |
02/13/2025 | 0.83 | 0.84 | 0.80 | 0.84 | 448,220 | |
02/12/2025 | 0.81 | 0.84 | 0.79 | 0.82 | 913,743 | |
02/11/2025 | 0.77 | 0.81 | 0.75 | 0.80 | 896,502 | |
02/10/2025 | 0.79 | 0.80 | 0.77 | 0.79 | 851,773 | |
02/07/2025 | 0.78 | 0.79 | 0.77 | 0.78 | 754,638 | |
02/06/2025 | 0.78 | 0.84 | 0.78 | 0.78 | 1,065,698 | |
02/05/2025 | 0.81 | 0.83 | 0.79 | 0.79 | 792,535 | |
02/04/2025 | 0.81 | 0.84 | 0.80 | 0.81 | 850,267 | |
02/03/2025 | 0.85 | 0.87 | 0.81 | 0.83 | 836,766 | |
01/31/2025 | 0.87 | 0.88 | 0.83 | 0.84 | 753,166 | |
01/30/2025 | 0.81 | 0.88 | 0.81 | 0.86 | 1,012,846 | |
01/29/2025 | 0.82 | 0.84 | 0.79 | 0.81 | 937,573 | |
01/28/2025 | 0.83 | 0.86 | 0.80 | 0.81 | 772,080 | |
01/27/2025 | 0.85 | 0.92 | 0.82 | 0.84 | 1,756,940 | |
01/24/2025 | 0.89 | 0.93 | 0.85 | 0.86 | 1,279,183 | |
01/23/2025 | 0.89 | 0.95 | 0.84 | 0.89 | 2,555,259 | |
01/22/2025 | 0.74 | 0.95 | 0.74 | 0.91 | 11,393,150 | |
01/21/2025 | 0.77 | 0.77 | 0.72 | 0.73 | 1,211,148 | |
01/17/2025 | 0.74 | 0.79 | 0.74 | 0.77 | 830,262 | |
01/16/2025 | 0.75 | 0.80 | 0.71 | 0.74 | 10,654,050 | |
01/15/2025 | 0.78 | 0.81 | 0.75 | 0.78 | 1,126,195 | |
01/14/2025 | 0.81 | 0.83 | 0.75 | 0.77 | 2,556,758 | |
01/13/2025 | 0.83 | 0.84 | 0.80 | 0.82 | 1,064,488 | |
01/10/2025 | 0.90 | 0.91 | 0.83 | 0.84 | 751,810 | |
01/08/2025 | 0.85 | 0.88 | 0.84 | 0.85 | 707,718 | |
01/07/2025 | 0.91 | 0.94 | 0.85 | 0.87 | 1,376,448 | |
01/06/2025 | 0.89 | 0.95 | 0.89 | 0.91 | 1,527,967 | |
01/03/2025 | 0.83 | 0.91 | 0.82 | 0.91 | 1,531,545 | |
01/02/2025 | 0.85 | 0.85 | 0.81 | 0.84 | 1,090,382 | |
12/31/2024 | 0.85 | 0.85 | 0.80 | 0.83 | 1,538,588 | |
12/30/2024 | 0.88 | 0.89 | 0.82 | 0.83 | 2,760,568 | |
12/27/2024 | 0.93 | 0.93 | 0.87 | 0.89 | 1,320,848 | |
12/26/2024 | 0.94 | 0.97 | 0.92 | 0.92 | 886,345 | |
12/24/2024 | 0.95 | 0.99 | 0.95 | 0.96 | 938,824 | |
12/23/2024 | 0.92 | 1.00 | 0.92 | 0.97 | 3,029,037 | |
12/20/2024 | 0.93 | 0.96 | 0.92 | 0.92 | 2,789,337 | |
12/19/2024 | 0.90 | 0.97 | 0.87 | 0.92 | 2,663,890 | |
12/18/2024 | 0.90 | 0.92 | 0.85 | 0.86 | 1,803,621 | |
12/17/2024 | 0.88 | 0.91 | 0.85 | 0.88 | 1,721,328 | |
12/16/2024 | 0.88 | 0.95 | 0.88 | 0.89 | 1,480,785 | |
12/13/2024 | 0.91 | 0.96 | 0.87 | 0.88 | 2,124,345 | |
12/12/2024 | 0.90 | 0.92 | 0.85 | 0.86 | 1,078,664 | |
12/11/2024 | 0.95 | 0.95 | 0.86 | 0.90 | 1,098,732 | |
12/10/2024 | 0.83 | 0.94 | 0.83 | 0.93 | 3,543,903 | |
12/09/2024 | 0.90 | 0.95 | 0.81 | 0.86 | 13,930,490 | |
12/06/2024 | 0.82 | 0.90 | 0.81 | 0.82 | 1,164,311 | |
12/05/2024 | 0.82 | 0.84 | 0.78 | 0.81 | 1,338,860 | |
12/04/2024 | 0.87 | 0.87 | 0.80 | 0.82 | 1,903,431 | |
12/03/2024 | 0.92 | 0.93 | 0.87 | 0.88 | 1,428,533 | |
12/02/2024 | 1.01 | 1.01 | 0.87 | 0.93 | 2,920,470 | |
11/29/2024 | 0.95 | 0.99 | 0.94 | 0.98 | 3,585,585 | |
11/27/2024 | 0.88 | 0.93 | 0.86 | 0.92 | 1,665,786 | |
11/26/2024 | 0.96 | 0.96 | 0.80 | 0.88 | 2,880,813 |
About Seres Therapeutics Stock history
Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 147.2 M | 154.6 M | |
Net Loss | -225.1 M | -213.9 M |
Seres Therapeutics Quarterly Net Working Capital |
|
Seres Therapeutics Stock Technical Analysis
Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
All Next | Launch Module |
Seres Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0837 | |||
Jensen Alpha | 0.6006 | |||
Total Risk Alpha | 0.5686 | |||
Sortino Ratio | 0.1574 | |||
Treynor Ratio | 0.337 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |